Monoclonal antibodies.

MT Marina Tuyishime
CG Carolina Garrido
SJ Shalini Jha
MM Matt Moeser
DM Dieter Mielke
CL Celia LaBranche
DM David Montefiori
BH Barton F. Haynes
SJ Sarah Joseph
DM David M. Margolis
GF Guido Ferrari
request Request a Protocol
ask Ask a question
Favorite

Six human mAbs targeting different regions of the Env, the non-neutralizing C1C2 (A32) (38), CD4bs (CH557) (39), V2 glycan (PG9) (40), V3 glycan (PGT121) (41), gp120-gp41 interface (PGT151) (42), and MPER (DH511.2K3) (43), were isolated from HIV-1–infected individuals, expressed as IgG1, and optimized for Fcγ receptor binding on the effector cells (80).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A